WG
CPRX

Winton Group’s Catalyst Pharmaceutical CPRX Stock Holding History

Winton Group’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.68M Sell
67,720
-285,809
-81% -$6.81M 0.06% 362
2025
Q4 		$8.25M Buy
353,529
+298,862
+547% +$6.66M 0.28% 88
2025
Q3 		$1.08M Buy
54,667
+4,673
+9% +$96.1K 0.04% 430
2025
Q2 		$1.08M Sell
49,994
-6,769
-12% -$160K 0.06% 404
2025
Q1 		$1.38M Sell
56,763
-2,510
-4% -$56.5K 0.08% 229
2024
Q4 		$1.24M Buy
59,273
+4
+0% +$86 0.08% 215
2024
Q3 		$1.18M Sell
59,269
-5,126
-8% -$95K 0.08% 206
2024
Q2 		$997K Buy
64,395
+110
+0.2% +$1.71K 0.07% 241
2024
Q1 		$1.02M Buy
+64,285
New +$969K 0.07% 241
2023
Q2 		– Sell
-20,158
Closed -$334K – 836
2023
Q1 		$334K Buy
20,158
+5,597
+38% +$92.3K 0.02% 795
2022
Q4 		$271K Sell
14,561
-8,943
-38% -$138K 0.02% 807
2022
Q3 		$302K Buy
+23,504
New +$279K 0.02% 793
2021
Q4 		– Sell
-142,529
Closed -$755K – 1086
2021
Q3 		$755K Buy
142,529
+5,313
+4% +$29.1K 0.04% 649
2021
Q2 		$789K Buy
137,216
+14,797
+12% +$76.4K 0.04% 658
2021
Q1 		$564K Buy
122,419
+36,545
+43% +$145K 0.03% 817
2020
Q4 		$287K Buy
85,874
+26,640
+45% +$89.5K 0.02% 1065
2020
Q3 		$176K Buy
+59,234
New +$232K 0.01% 1361
2019
Q2 		– Sell
-12,454
Closed -$64K – 1152
2019
Q1 		$64K Buy
+12,454
New +$36.6K ﹤0.01% 1046

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Winton Group's CPRX Position: Q1 2026 in Review

Winton Group reduced its Catalyst Pharmaceutical (CPRX) stake by 81% in Q1 2026, selling an estimated $6.81M and leaving 67,720 shares worth $1.68M. The position accounts for 0.06% of the portfolio, ranked #362.

Winton Group first reported a position in CPRX in Q1 2019 and has held it in 18 quarters since. The position peaked at $8.25M in Q4 2025. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Winton Group held 67,720 shares of Catalyst Pharmaceutical worth $1.68M as of Q1 2026.
  • Winton Group sold 285,809 Catalyst Pharmaceutical shares in Q1 2026, an estimated $6.81M.
  • Catalyst Pharmaceutical made up 0.06% of Winton Group's portfolio in Q1 2026, its #362 holding.
  • Winton Group first reported a position in Catalyst Pharmaceutical in Q1 2019 and has held it in 18 quarters since.
  • Winton Group's Catalyst Pharmaceutical position peaked at $8.25M in Q4 2025.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Winton Group's 13F filing for Q1 2026, filed 12 May 2026.